In-Depth PIB Analysis2 Items

Core TopicImportantConcise

International Relations & DefenceGS Paper II & III

01RAKSHA — India's Defence Diplomacy Document

Science & Technology / EconomyGS Paper III

02BIO-NIVESH — Biotech Investment Platform

International Relations & DefenceGeneral Studies Paper II & III

01

'RAKSHA' Document: India Lays Out 10-Year Defence Diplomacy Roadmap

GS-II · IR — Bilateral & Multilateral Groupings; Defence DiplomacyGS-III · Defence — Make in India; Maritime SecurityPrelims + MainsPIB · Ministry of Defence · 03 Sep 2026

India has formalised its defence diplomacy strategy for the first time in a named, publicly released document — 'RAKSHA' — providing a structured, decade-long framework to align security partnerships with foreign policy objectives.

◈ Background & Context

Defence diplomacy — the use of military instruments to build inter-state relationships short of combat — has historically been an informal adjunct to India's foreign policy. Bilateral agreements, joint exercises, and arms sales occurred without an overarching public doctrine.

The release of RAKSHA (Roadmap for Advancing Kinship, Security and Harmony Abroad) on 3 September 2026 by Raksha Mantri Rajnath Singh marks a deliberate shift towards structured, transparent strategic communication.

• Why now? Growing multipolarity, demand from Global South partners for capacity building, and India's expanding defence export target (₹50,000 crore by 2029 under iDEX/DPP) required a cohesive public framework.
• Signatories to the doctrine: The document was presented alongside the Defence Secretary, MEA Secretary (East), and all three service chiefs — underscoring its whole-of-government character.
• India–Belgium context: The same day, the document's priorities were reinforced during Rajnath Singh's bilateral talks with Belgium's Defence Minister on co-development and co-production.

▤ Document at a Glance

• Full name: RAKSHA — India's Defence Diplomacy Document
• Released by: Raksha Mantri Shri Rajnath Singh, New Delhi, 3 September 2026
• Horizon: 10 years (2026–2036)
• Nodal Ministry: Ministry of Defence
• Nature: Strategic framework document (not a legislation or scheme); provides an actionable vision for bilateral and multilateral defence engagement
• Coverage: Bilateral security partnerships, capacity building, indigenous defence exports, maritime security
• Key institutions involved: Ministry of Defence, Ministry of External Affairs, National Security Council Secretariat, all three Service Headquarters

Four Pillars of RAKSHA

• Strategic Partnerships: Deepening bilateral and multilateral security cooperation — moving beyond ad-hoc MOUs to structured, long-term frameworks with like-minded nations.
• Capacity Building: Expanded joint military exercises, structured training programmes, and sharing of best practices with partner countries — particularly in the Indo-Pacific and African regions.
• Indigenous Exports (Make in India): Positioning India as a reliable global defence manufacturing hub; promoting domestic platforms — LCA Tejas, ALH Dhruv, BrahMos, Pinaka — in overseas markets. India's defence exports crossed ₹21,083 crore in FY 2023–24, a more than 30-fold rise over the past decade.
• Maritime Security: Formalising India's role as Net Security Provider and First Responder in the Indian Ocean Region (IOR) — building on SAGAR (Security and Growth for All in the Region) doctrine and ongoing missions like Mission Sagar.

Figure 1 — RAKSHA: Four Strategic Pillars of India's Defence Diplomacy

RAKSHA10-Year Defence Diplomacy RoadmapStrategic PartnershipsBilateral & multilateralsecurity cooperationCapacity BuildingJoint exercises, training& best practicesIndigenous ExportsMake-in-India defencemanufacturing hubMaritime SecurityNet Security Providerin Indian Ocean Region

RAKSHA organises India's defence engagement around four interlocking pillars — strategic partnerships, capacity building, indigenous exports, and maritime security — under a single 10-year vision.

Static Background: India's Defence Diplomacy — Evolution

• SAGAR Doctrine (2015): PM Modi's vision of Security and Growth for All in the Region — India's first articulated maritime-security framework for the IOR; RAKSHA operationalises and extends it.
• Defence Exports trajectory: India's exports were a negligible ₹686 crore in FY 2013–14; they crossed ₹21,083 crore in FY 2023–24. The Government's target is ₹50,000 crore by 2029.
• iDEX (Innovations for Defence Excellence), 2018: Fostered startup-led defence innovation; DPIIT now permits 100% FDI in defence manufacturing via automatic route (up to 74%).
• Defence Production Policy (DPP) / DAP 2020: Governs procurement priorities; indigenisation lists (Positive Indigenisation List) restrict imports to promote domestic manufacturing.
• Net Security Provider concept: India's assistance during disasters (Operation Maitri — Nepal 2015; Mission Sagar — COVID relief 2020; HADR operations in Türkiye earthquake 2023) laid the operational foundation for this role.
• 2+2 Ministerial Dialogues: India holds 2+2 (Foreign + Defence Ministers) formats with the US, Japan, Australia, and Russia — the institutional framework RAKSHA's partnership pillar builds upon.
• India and AUKUS: India is not a member but is watching the trilateral as it reshapes IOR security architecture — relevant for UPSC questions on Indo-Pacific alignments.

Critical View

• Implementation gap: India has previously released defence industrial roadmaps (DPP 2016, DAP 2020) with ambitious targets; actual indigenisation progress has been uneven. RAKSHA's effectiveness will depend on execution rather than articulation.
• Balancing act: India's strategic autonomy principle constrains deep alignment with any single bloc. RAKSHA must balance QUAD commitments, SCO obligations, and the Russia relationship — contradictions the document does not publicly resolve.
• Export credibility: Scaling defence exports requires competitive pricing, reliable after-sales support, and ITAR-waiver equivalents — India is still building these ecosystems. The BrahMos deal with the Philippines remains the flagship benchmark.
• Maritime security vs. sovereignty: India's First Responder role in the IOR is welcomed by smaller island nations but could be read as hegemonic by Pakistan or China — a diplomatic tightrope.

Key Terms for Prelims

• RAKSHA: India's Defence Diplomacy Document released Sep 2026; 10-year strategic framework.
• Net Security Provider: A nation that contributes to regional security beyond its own territory — India's stated aspiration in the IOR.
• SAGAR: Security and Growth for All in the Region — PM Modi's 2015 IOR maritime doctrine.
• iDEX: Innovations for Defence Excellence — DRDO/MoD startup engagement platform.
• Positive Indigenisation List: MoD list of defence items that cannot be imported; promotes domestic manufacturing.
• HADR: Humanitarian Assistance and Disaster Relief — a core operational role under India's Net Security Provider mandate.
• 2+2 Dialogue: Ministerial format involving Foreign and Defence Ministers of two countries; India holds this with US, Japan, Australia, Russia.

✎ Mains Practice Question

India's release of the 'RAKSHA' defence diplomacy document marks a transition from ad-hoc military engagement to a structured, doctrine-driven foreign policy instrument. Critically examine the strategic rationale behind this shift and assess the challenges India faces in translating its defence diplomacy ambitions into durable partnerships. 15 marks · 250 words

Science & Technology / EconomyGeneral Studies Paper III

02

BIO-NIVESH: Government Launches Platform to Channel Private Capital into Biotechnology Scale-Up

GS-III · S&T — Biotechnology; Innovation EcosystemGS-III · Economy — Startups; Industrial Policy; InvestmentPrelims + MainsPIB · Ministry of Science & Technology · DBT · 03 Sep 2026

BIO-NIVESH, launched by the Department of Biotechnology on 3 September 2026, is a structured engagement platform that brings biotechnology innovators and private investors into a recurring dialogue — aimed at mobilising private capital into a sector the Government considers central to India's next industrial leap.

◈ Background & Context

India's bioeconomy reached ₹4 lakh crore (~$50 billion) in 2024, with an aspirational target of ₹20 lakh crore by 2030.

Despite a rich pipeline of BIRAC-funded innovations, many promising ventures stall at the 'valley of death' — the gap between lab-stage proof-of-concept and commercially scalable production — because domestic patient capital for deep-science startups remains scarce.

• Why the gap matters: Biotechnology has long development cycles (10–15 years from lab to market), high regulatory hurdles, and large capital requirements — characteristics that discourage short-cycle venture capital.
• Policy context: BIO-NIVESH aligns with the National Biopharma Mission, BioE3 Policy (Biotechnology for Economy, Environment and Employment), and the broader RDI Fund (₹1 lakh crore).
• Inaugural edition: 20 deep-tech/biotech startups and approximately 50 curated investors participated; BIRAC is the organising body.

▤ BIO-NIVESH at a Glance

• Full name: BIO-NIVESH (platform name; not an acronym)
• Launched by: Dr. Jitendra Singh, Minister of State (I/C), Science & Technology, 3 September 2026
• Nodal body: BIRAC (Biotechnology Industry Research Assistance Council), under the Department of Biotechnology (DBT), Ministry of Science & Technology
• Nature: Recurring investor-innovator connect platform (not a fund or scheme); first edition held in New Delhi
• Coverage: Biotechnology and deep-tech startups across health, agriculture, environment, and industrial biotech verticals
• RDI Fund link: BIRAC designated as Second-Level Fund Manager under the ₹1 lakh crore Research, Development and Innovation Fund for biotech sector
• Format: Startup–Investor Connect sessions + ministerial roundtable; proposed expansion to multiple cities
• Inaugural numbers: 20 startups selected; ~50 investors; startups chosen on innovation, development stage, market potential, scalability, and regulatory readiness

How BIO-NIVESH Works

• Two-way engagement: Unlike conventional pitch events, BIO-NIVESH is designed to educate investors on biotechnology's regulatory and development pathways, while helping innovators understand the investment thesis and due-diligence lens.
• Startup–Investor Connect: Direct structured interactions between vetted startups and a curated investor cohort — prioritising scientific depth alongside commercial viability.
• Government as catalyst: The Government's role is explicitly framed as reducing early-stage risk to make innovations investable, not as a substitute for private capital.
• 'Big Five in Five Years' idea: The Minister floated a concept of creating a small number of large anchor biotech companies to anchor the wider startup ecosystem — drawing parallels with the space sector's privatisation experience.

Figure 2 — India's Bioeconomy: Growth Trajectory and Target

05101520₹ lakh crore₹0.1 L Cr2014₹0.8 L Cr2020₹4 L Cr2024₹20 L Cr2030**TargetAchievedTarget

India's bioeconomy has grown nearly 40× in a decade (2014–2024) and the Government's stated target is a further 5× growth to ₹20 lakh crore by 2030 — making investor mobilisation through platforms like BIO-NIVESH critical. Data: DBT/BIRAC; target is government projection.

Static Background: India's Biotechnology Ecosystem

• BIRAC (Biotechnology Industry Research Assistance Council), 2012: A Public Sector Undertaking under DBT; provides grant funding, equity, and mentoring to biotech startups. Key programmes include SPARSH, BISS, PACE, LEAP.
• National Biopharma Mission (NBM), 2017: A ₹1,500 crore mission to develop affordable biopharmaceuticals; implemented by BIRAC.
• BioE3 Policy (2024): Biotechnology for Economy, Environment and Employment — India's overarching biotech industrial policy promoting high-performance biomanufacturing.
• RDI Fund (₹1 lakh crore): Announced in Union Budget 2024–25 for long-term patient capital for technology development; BIRAC is the Second-Level Fund Manager for biotech.
• India's biotech sector strengths: India is the 3rd largest biotech destination in the Asia-Pacific; has over 6,900 registered biotech startups; Serum Institute of India produces ~60% of world's vaccines by volume.
• Valley of Death: The stage between proof-of-concept and commercial scale-up where most deep-science ventures fail due to funding gaps — the specific problem BIO-NIVESH addresses.
• Comparison — Space sector: India's liberalisation of the space sector through IN-SPACe and the New Space India Limited has attracted significant private investment; BIO-NIVESH draws on this model.

Critical View

• Structural challenge: The 'valley of death' in biotech is partly a function of India's thin domestic venture capital ecosystem for deep science. A networking platform alone — without tax incentives, long-lock-in fund structures, or regulatory fast-tracks — may not be sufficient.
• Regulatory bottleneck: India's drug and GMO regulatory pathways (CDSCO, GEAC) are noted for delays. BIO-NIVESH's success depends on parallel regulatory reform, which the platform itself cannot deliver.
• IP and data concerns: Deep-science startups are often reluctant to pitch publicly before IP protection is secured. The platform must build mechanisms to ensure investor NDAs and data confidentiality.
• 'Big Five' risk: Concentrating resources to build a few large anchor companies could inadvertently crowd out smaller innovators — the usual critique of industrial policy favouritism.

Key Terms for Prelims

• BIO-NIVESH: DBT/BIRAC platform for biotech investor-innovator engagement; launched Sep 2026.
• BIRAC: Biotechnology Industry Research Assistance Council — PSU under DBT; central biotech funding body.
• BioE3 Policy: Biotechnology for Economy, Environment & Employment — India's 2024 biotech industrial policy.
• RDI Fund: ₹1 lakh crore Research, Development & Innovation Fund (Budget 2024–25); BIRAC = Second-Level Fund Manager for biotech.
• Valley of Death: Funding gap between lab-scale proof-of-concept and commercially viable scale-up — the core problem BIO-NIVESH targets.
• Bioeconomy target: India aims to reach ₹20 lakh crore (~$250 billion) bioeconomy by 2030.
• IN-SPACe: Indian National Space Promotion and Authorisation Centre — model for private-sector space engagement that BIO-NIVESH parallels for biotech.

✎ Mains Practice Question

India's biotechnology sector has grown rapidly but continues to struggle with the 'valley of death' — the gap between scientific innovation and commercial scale. Evaluate the role of government-led platforms like BIO-NIVESH in bridging this gap, and discuss the structural reforms necessary to build a self-sustaining private investment ecosystem for deep-science startups in India. 15 marks · 250 words